SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,640.00    -10.00 (-0.18%)
Bid:
5,640.00
Ask:
5,670.00
Spread: 30.00 (0.532%)
Market Cap: £3.02b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

3rd Quarter Trading Statement

1 Feb 2008 07:01

Cranswick PLC01 February 2008 Cranswick plc ("Cranswick" or "the Company") - third quarter trading statement Total sales for the Company in the quarter to 31 December 2007 were £158m, anincrease of 18 per cent compared to the same period last year after adjustingfor the impact of the sale of the animal feeds business in May 2007. In the food division, turnover increased by 17 per cent compared with the sameperiod last year, which was pleasing given strong comparatives. Most productcategories showed double digit growth, with sausage and bacon performingparticularly well and benefiting from investment in additional capacity duringthe year. Production of premium bacon from the new factory at Sherburn-in-Elmetcommenced on schedule, enabling the high December demand to be met and baconactivities are currently being consolidated on to this site. Turnover in the pet division, which accounted for 6 per cent of total Companysales in the quarter, was up by 37 per cent following better bird food sales.The aquatics business is now fully operative at Chorleywood following a fire inDecember 2006. There has been significant raw material price inflation in thepet food business, most of which has now been passed on in the finished productprice. During the second half, the food division has suffered from some sales pricedeflation. Furthermore, the industry is experiencing rising input costs in pigmeat, beef and poultry. Whilst Cranswick is benefiting from higher than plannedvolume gains, it is currently proving difficult to pass on the full impact ofrising costs. Discussions on this are ongoing with customers. Assuming acontinuation of current conditions, the impact of these two factors, togetherwith the impact of the fall in the value of sterling on the charcuteriebusiness, is expected to have a modest negative impact on the results to 31March 2008. The Directors expect the effect of these issues in the current yearto be approximately matched by exceptional gains of around £1.8m. Whilst it is disappointing to be experiencing these pressures, which can beexpected to moderate the Company's growth rate, Cranswick is in a very strongposition to capitalise once equilibrium returns to input prices and sellingprices. Our market positions are strong, our plants are well invested, thebusiness is highly cash generative and we have excellent customer relationships. Enquiries: CityRoad Communications Paul Quade 020 7248 8010 (mobile 07947 186694) This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Mar 20257:05 amRNSDirectorship
5th Mar 20252:24 pmRNSTotal Voting Rights
3rd Mar 20253:27 pmRNSHolding(s) in Company
24th Feb 20254:54 pmRNSDirector/PDMR Shareholding
10th Feb 20252:51 pmRNSAdditional Listing
3rd Feb 202510:04 amRNSTotal Voting Rights
22nd Jan 20251:21 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSQ3 Trading Update and Acquisition of JSR Genetics
7th Jan 20254:02 pmRNSTotal Voting Rights
27th Dec 20247:00 amRNSDirector/PDMR Shareholding
11th Dec 20243:26 pmRNSHolding(s) in Company
3rd Dec 20249:53 amRNSTotal Voting Rights
26th Nov 20247:00 amRNSINTERIM RESULTS
13th Nov 202411:41 amRNSTotal Voting Rights
1st Oct 202412:46 pmRNSTotal Voting Rights
1st Oct 202412:43 pmRNSBlock Listing LTIP return
1st Oct 202412:41 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 202412:38 pmRNSDirector/PDMR Shareholding
27th Sep 20247:00 amRNSHalf Year Trading Update
25th Sep 20243:19 pmRNSDirector/PDMR Shareholding
16th Sep 202411:56 amRNSHolding(s) in Company
16th Sep 202411:55 amRNSHolding(s) in Company
12th Aug 202412:15 pmRNSDirector/PDMR Shareholding
6th Aug 20244:20 pmRNSDirector/PDMR Shareholding
5th Aug 202412:18 pmRNSDirector/PDMR Shareholding
5th Aug 202412:16 pmRNSDirector/PDMR Shareholding
5th Aug 202412:15 pmRNSDirector/PDMR Shareholding
5th Aug 202412:11 pmRNSDirector/PDMR Shareholding
1st Aug 202410:52 amRNSTotal Voting Rights
29th Jul 20244:02 pmRNSAGM Statement
29th Jul 20247:00 amRNSFirst quarter trading statement
3rd Jun 20249:42 amRNSTotal Voting Rights
21st May 20247:00 amRNSPreliminary Results
15th May 20245:22 pmRNSDirector/PDMR Shareholding
2nd May 20249:26 amRNSTotal Voting Rights
2nd Apr 20241:55 pmRNSBlock listing Interim Review
2nd Apr 20241:54 pmRNSBlock listing Interim Review
2nd Apr 20241:50 pmRNSTotal Voting Rights
27th Mar 20249:58 amRNSDirector/PDMR Shareholding
21st Mar 20241:57 pmRNSDirector/PDMR Shareholding
21st Mar 20241:55 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirectorate Change
15th Mar 20243:58 pmRNSDirector/PDMR Shareholding
4th Mar 20249:58 amRNSTotal Voting Rights
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
2nd Feb 202411:00 amRNSTotal Voting Rights
18th Jan 20247:00 amRNSThird quarter trading statement
3rd Jan 20247:00 amRNSDirector/PDMR Shareholding
2nd Jan 20243:05 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.